Boston Scientific Corporation
Capitalisation boursière
$73.1B
Rang mondial
#217
Sommet historique
$141.7B
2025-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 41% of the 367 companies we track (globally).
- Equivalent to 0.2% of United States's GDP (2025 data).
- Just above: #216 O'Reilly Automotive, Inc. ($73.4B)
- Just below: #218 Colgate-Palmolive Company ($72.9B)
- Best year: 1995 (+183%). Worst year: 2026 (-48%).
Boston Scientific Corporation Financial Breakdown (FY 2025)
Source: Yahoo Finance — BSX annual filings (2025) →$20.1B revenue · $4.0B operating income · $2.9B net income
- ●Operating margin: 19.8% on $20.1B in revenue.
- ●R&D is 10.2% of revenue ($2.1B).
- ●Net income margin: 14.4% — $2.9B in profit.
- ●Free cash flow: $3.4B (17.0% of revenue).
Cost / Operating Expenses
Total operating expenses $16.1B
Total
$15.2B
Capital Expenditures
$1.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$3.4B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Boston Scientific Corporation
Boston Scientific Corporation (BSC) is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Historique de la capitalisation boursière de Boston Scientific Corporation (2026–2026)
Boston Scientific Corporation vs Sector Peers by Market Cap
Comparer Boston Scientific Corporation
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $73.1B | #217(↓105) | -48.4% |
| 2025 | $141.7B | #112(↓14) | +6.8% |
| 2024 | $132.8B | #98(↑34) | +54.5% |
| 2023 | $85.9B | #132(↓1) | +24.9% |
| 2022 | $68.8B | #131(↑22) | +8.9% |
| 2021 | $63.1B | #153(↑12) | +18.2% |
| 2020 | $53.4B | #165(↓63) | -20.5% |
| 2019 | $67.2B | #102(↓8) | +28.0% |
| 2018 | $52.5B | #94(↑66) | +42.6% |
| 2017 | $36.8B | #160(↓18) | +14.6% |
| 2016 | $32.1B | #142(↑6) | +17.3% |
| 2015 | $27.4B | #148(↑46) | +39.2% |
| 2014 | $19.7B | #194(↓8) | +10.2% |
| 2013 | $17.9B | #186(↑36) | +109.8% |
| 2012 | $8.5B | #222(↓15) | +7.3% |
| 2011 | $7.9B | #207(↓27) | -29.5% |
| 2010 | $11.3B | #180(↓37) | -15.9% |
| 2009 | $13.4B | #143(↓23) | +16.3% |
| 2008 | $11.5B | #120(↑8) | -33.4% |
| 2007 | $17.3B | #128(↓59) | -32.3% |
| 2006 | $25.5B | #69(↓28) | -29.8% |
| 2005 | $36.4B | #41(↓25) | -31.1% |
| 2004 | $52.8B | #16(↓1) | -3.3% |
| 2003 | $54.6B | #15(↑11) | +72.9% |
| 2002 | $31.6B | #26(↑35) | +76.3% |
| 2001 | $17.9B | #61(↑32) | +76.2% |
| 2000 | $10.2B | #93(↓34) | -37.4% |
| 1999 | $16.3B | #59(↓18) | -18.4% |
| 1998 | $19.9B | #41(↓3) | +16.9% |
| 1997 | $17.0B | #38(↓17) | -23.5% |
| 1996 | $22.3B | #21(↓1) | +21.8% |
| 1995 | $18.3B | #20(↑12) | +183.5% |
| 1994 | $6.5B | #32 |
Autres entreprises du secteur Santé
FAQ
What is Boston Scientific Corporation's market cap?
Boston Scientific Corporation (BSX) has a market capitalization of $73.1B, making it the #217 largest company in the world by market cap.
What was Boston Scientific Corporation's highest market cap?
Boston Scientific Corporation's all-time high market cap was $141.7B, reached in 2025-12-31. Its highest rank was #112 in 2025.
What sector is Boston Scientific Corporation in?
Boston Scientific Corporation is in the Healthcare sector, specifically the Medical Devices industry. It is based in United States.
How has Boston Scientific Corporation's market cap changed over time?
Boston Scientific Corporation has been tracked since 2026. Its market cap has grown by 0% from $73.1B in 2026 to $73.1B today.